Varenicline Label Changes Downplay Suicide RiskVarenicline Label Changes Downplay Suicide Risk

New data suggest lower neuropsychiatric risks with the smoking cessation drug varenicline. The FDA is set to review these new safety data at an upcoming meeting. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Psychiatry News Source Type: news